Skip to main content
Premium Trial:

Request an Annual Quote

LabCorp to Sell Roche s AmpliChip CYP450 Assay

NEW YORK, Nov. 28 (GenomeWeb News) - Laboratory Corporation of America will sell Roche Diagnostics' Cytochrome AmpliChip P450 2D6/2C19 genotyping and phenotyping assay, the company said today.

 

The assay, approved by the US Food and Drug Administration in January, is designed to identify multiple genetic variants in two cytochrome P450 genes, CYP2D6 and CYP2C19, which metabolize 40 to 45 percent of all prescription drugs, including antidepressants, pain relievers, and cardiovascular agents.

 

This summer, the reference lab helped validate the chip for Roche, and worked with the Swiss diagnostic giant evaluate its research leukemia microarray, which is currently in development.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.